Achieve Life Sciences Inc (NASDAQ: ACHV) on Tuesday, soared 5.86% from the previous trading day, before settling in for the closing price of $4.44. Within the past 52 weeks, ACHV’s price has moved between $1.84 and $5.78.
Annual sales at Healthcare sector company grew by 50.01% over the past five years. The company achieved an average annual earnings per share of -2.90%. With a float of $46.63 million, this company’s outstanding shares have now reached $52.81 million.
Achieve Life Sciences Inc (ACHV) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Achieve Life Sciences Inc is 12.41%, while institutional ownership is 40.05%. The most recent insider transaction that took place on Sep 18 ’25, was worth 146,175. In this transaction Chief Financial Officer of this company sold 50,060 shares at a rate of $2.92, taking the stock ownership to the 127,940 shares. Before that another transaction happened on Sep 18 ’25, when Company’s Chief Executive Officer sold 129,501 for $2.92, making the entire transaction worth $378,143. This insider now owns 228,875 shares in total.
Achieve Life Sciences Inc (ACHV) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.36 earnings per share (EPS) for the period topping the consensus outlook (set at -0.36) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 46.96% during the next five years compared to 50.01% growth over the previous five years of trading.
Achieve Life Sciences Inc (NASDAQ: ACHV) Trading Performance Indicators
Achieve Life Sciences Inc (ACHV) is currently performing well based on its current performance indicators. A quick ratio of 5.14 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.38, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Achieve Life Sciences Inc (ACHV)
Achieve Life Sciences Inc (NASDAQ: ACHV) saw its 5-day average volume 0.68 million, a negative change from its year-to-date volume of 0.79 million. As of the previous 9 days, the stock’s Stochastic %D was 62.16%.
During the past 100 days, Achieve Life Sciences Inc’s (ACHV) raw stochastic average was set at 68.32%, which indicates a significant increase from 65.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was lower than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.63, while its 200-day Moving Average is $3.29. Nevertheless, the first resistance level for the watch stands at $5.00 in the near term. At $5.30, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.65. If the price goes on to break the first support level at $4.35, it is likely to go to the next support level at $4.00. Assuming the price breaks the second support level, the third support level stands at $3.70.
Achieve Life Sciences Inc (NASDAQ: ACHV) Key Stats
Market capitalization of the company is 250.20 million based on 53,234K outstanding shares. Right now, sales total 0 K and income totals -39,830 K. The company made 0 K in profit during its latest quarter, and -14,440 K in sales during its previous quarter.
